akari立克次体 IgG ELISA试剂盒

R. akari IgG ELISA Kit

广州健仑生物科技有限公司

主要用途：用于检测人血清中的akari立克次体IgG抗体

产品规格：96T/盒

主要产品包括：包柔氏螺旋体菌、布鲁氏菌、贝纳特氏立克次体、土伦杆菌、钩端螺旋体、新型立克次体、恙虫病、立克次体、果氏巴贝西虫、马焦虫、牛焦虫、利什曼虫、新包虫、弓形虫、猫流感病毒、猫冠状病毒、猫疱疹病毒、犬瘟病毒、犬细小病毒等病原微生物的 IFA、MIF、ELISA试剂。

akari立克次体 IgG ELISA试剂盒

我司还提供其它进口或国产试剂盒：登革热、疟疾、西尼罗河、立克次体、无形体、蜱虫、恙虫、利什曼原虫、RK39、汉坦病毒、深林脑炎、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

二维码扫一扫

【公司名称】 广州健仑生物科技有限公司
【】    杨永汉 
【】 
【腾讯 】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室
【企业文化】

利用酵母和人类细胞，Smerdon，Mao和他们的研究团队发现，正常的TCR修复过程有两个关键的步骤，以及一种叫做H2B的染色质蛋白质在*步中起着至关重要的作用。
为了帮助修复酶能够进入被大力保护的DNA中，H2B首先会解开一个较小的蛋白质的扣子，就像你在一顿丰富的大餐后放松你的皮带一样，这使得DNA链放松和分开。随着链的打开，维修人员才有空间进来和清楚损伤区域。
这较小的蛋白质的解开，被称为deubiquitylation。Smerdon和Mao说，这个过程使得DNA的修复效率更高，并且没有它的修复是不可能的。
他们的发现作为进一步研究染色质中的DNA修复在很大程度上的未知领域的基础。他们的目标是更好地了解这一过程在人类身上的工作机理。
基因疗法
“即使在基本技术层面上，我也没有忽视这项研究zui终对人体健康而言所能做的，” Smerdon说。
“其中一个正在开发的治疗方法是靶向基因疗法，”他说。“如果一个病人有一个特定的基因突变，这个疗法会为他们提供一个正常的拷贝来试图纠正变异基因。虽然它已在某些疾病已经成功地做到这一点，但它仍然被修复缺陷案例中研究。”
Mao推测，在未来，有DNA修复问题的人可能会吃一种可以提供修复酶活性的药物，就可以达到治疗的目的。但这个想法还没有任何临床试验。
周围神经损伤后的自身功能恢复往往有限，因此，生物工程神经移植物复合细胞外基质分子，生长因子,药物学辅助，及细胞移植修复周围神经损伤等都成为研究热点。脂肪干细胞已被证实具有成脂肪，成骨，成软骨 多种分化潜能，因其材料来源广泛，取材容易，分化为神经元能力强，伦理学争议少等优点，使其成为神经导管上覆盖的优秀种子细胞。
英国曼彻斯特大学炎症与修复研究所Blond McIndoe 实验室主要研究GABA及其他神经递质周围神经系统及成体干细胞中的作用，他们发现，特异性抑制P2X7受体能够拯救ATP诱发细胞死亡，这可能解决神经损伤处干细胞移植成活率低的问题。作者的研究可能为神经修复结合细胞疗法和药物干预的发展指出新的方向。相关研究观点发表在《中国神经再生研究(英文版)》杂志2014年7月第14 期杂志上。

Using yeast and human cells, Smerdon, Mao and their team found two key steps in the normal TCR repair process, as well as a chromatin protein called H2B that plays a crucial role in the first step.
To help the repair enzyme get into well-protected DNA, H2B will first unbutton a smaller protein just as you relax your belt after a rich meal, which relaxes and separates the DNA strand . As the chain opens, maintenance personnel have room to come in and clear the damaged area.
The solution of this smaller protein is called deubiquitylation. Smerdon and Mao said that this process makes the DNA repair more efficient, and without its repair is impossible.
Their findings serve as a basis for furthering the largely unknown area of ??DNA repair in chromatin. Their goal is to better understand the working mechanism of this process on human beings.
Gene therapy
"Even at the basic technical level, I did not neglect what the research could ultimay do to human health," Smerdon said.
"One of the treatments that is being developed is targeted gene therapy," he said. "If a patient has a particular mutation, the therapy will provide them with a normal copy in an attempt to correct the variant gene.Although it has been successfully done in certain diseases, it is still being fixed in the case of defects the study."
Mao speculated that in the future, people with DNA repair problems may eat a drug that provides repair enzyme activity for therapeutic purposes. But this idea has not had any clinical trial yet.
Peripheral nerve injury after their own functional recovery is often limited, therefore, bioengineered nerve graft compound extracellular matrix molecules, growth factors, pharmacological assistance, and cell transplantation to repair peripheral nerve injury have become the research hotspot. Adipose-derived stem cells have been proven to have multiple adipogenic, osteogenic, and cartilage potential for differentiation because of their wide range of materials, ease of harvesting, strong ability to differentiate into neurons, and less ethical controversy that make them neurotransduction-covered Excellent seed cells.
The Blond McIndoe Laboratory at the Institute of Inflammation and Rehabilitation, University of Manchester, UK, has been investigating the role of GABA and other neurotransmitter peripheral and adult stem cells. They found that specifically inhibiting P2X7 receptors can rescue ATP-induced cell death, which may account for nerve Damage stem cell transplantation survival rate is low. The authors study may point out a new direction for the development of neurorestoratin combined with cell therapy and drug intervention. Relevant research point of view published in the "Chinese Journal of Nerve Regeneration Research (English version)" magazine in July 2014 No. 14 magazine.